Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syndax Pharmaceuticals Inc (SNDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $18.2651, valued at
$965.4k
Exercised 52,855 options to buy
@ $8.77, valued at
$463.5k
|
|
| 08/03/2023 |
4
| Meury William (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 35,000 shares
@ $20.4556, valued at
$715.9k
Sold 24,000 shares
@ $20.4563, valued at
$491k
Sold 24,000 shares
@ $20.4547, valued at
$490.9k
Exercised 24,000 options to buy
@ $9.47, valued at
$227.3k
Exercised 24,000 options to buy
@ $7.88, valued at
$189.1k
Exercised 35,000 options to buy
@ $7.11, valued at
$248.9k
|
|
| 07/11/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $20.3967, valued at
$1.1M
Exercised 52,855 options to buy
@ $8.77, valued at
$463.5k
|
|
| 06/09/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 24,582 shares
@ $21.1791, valued at
$520.6k
Sold 28,273 shares
@ $21.1791, valued at
$598.8k
Exercised 28,273 options to buy
@ $8.77, valued at
$248k
Exercised 24,582 options to buy
@ $6.38, valued at
$156.8k
|
|
| 05/10/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,855 shares
@ $21.4072, valued at
$1.1M
Exercised 52,855 options to buy
@ $6.38, valued at
$337.2k
|
|
| 03/14/2023 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,854 shares
@ $22.5276, valued at
$1.2M
Exercised 52,854 options to buy
@ $6.38, valued at
$337.2k
|
|
| 02/08/2023 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 5,959 shares
@ $27.6384, valued at
$164.7k
Exercised 5,959 options to buy
@ $6.38, valued at
$38k
|
|
| 02/08/2023 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 52,854 shares
@ $26.8269, valued at
$1.4M
Exercised 52,854 options to buy
@ $6.38, valued at
$337.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 24,000 shares
@ $26.7409, valued at
$641.8k
Sold 10,000 shares
@ $27, valued at
$270k
Sold 5,000 shares
@ $27, valued at
$135k
Exercised 24,000 options to buy
@ $9.47, valued at
$227.3k
Exercised 10,000 options to buy
@ $13.58, valued at
$135.8k
Exercised 5,000 options to buy
@ $13.58, valued at
$67.9k
|
|
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2022 |
4
| Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 20,782 shares
@ $25.9009, valued at
$538.3k
Sold 9,117 shares
@ $25.9009, valued at
$236.1k
Exercised 9,117 options to buy
@ $8.93, valued at
$81.4k
Exercised 20,782 options to buy
@ $7.88, valued at
$163.8k
|
|
| 10/07/2022 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 16,231 shares
@ $25.2916, valued at
$410.5k
Exercised 16,231 options to buy
@ $8.77, valued at
$142.3k
|
|
| 10/04/2022 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 29,606 shares
@ $25.0205, valued at
$740.8k
Sold 2,883 shares
@ $25.011, valued at
$72.1k
Sold 1,280 shares
@ $25.0206, valued at
$32k
Exercised 29,606 options to buy
@ $8.77, valued at
$259.6k
Exercised 2,883 options to buy
@ $8.77, valued at
$25.3k
Exercised 1,280 options to buy
@ $8.77, valued at
$11.2k
|
|
| 10/04/2022 |
4
| Katkin Keith (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 2,914 shares
@ $25.0707, valued at
$73.1k
Sold 647 shares
@ $25.0707, valued at
$16.2k
Sold 167 shares
@ $25, valued at
$4.2k
Sold 13 shares
@ $25, valued at
$325
Sold 137 shares
@ $25, valued at
$3.4k
Sold 223 shares
@ $25, valued at
$5.6k
Exercised 647 options to buy
@ $8.93, valued at
$5.8k
Exercised 2,914 options to buy
@ $7.88, valued at
$23k
Exercised 13 options to buy
@ $8.93, valued at
$116.1
Exercised 167 options to buy
@ $7.88, valued at
$1.3k
Exercised 223 options to buy
@ $8.93, valued at
$2k
|
|
| 09/21/2022 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 114,339 shares
@ $23.0284, valued at
$2.6M
Sold 59,649 shares
@ $23.2529, valued at
$1.4M
Exercised 114,339 options to buy
@ $10.9, valued at
$1.2M
Exercised 59,649 options to buy
@ $10.9, valued at
$650.2k
|
|
| 09/16/2022 |
4
| Morrison Briggs (President, Head of R&D) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 87,645 shares
@ $23.7989, valued at
$2.1M
Sold 66,775 shares
@ $24.2012, valued at
$1.6M
Sold 71,966 shares
@ $23.2195, valued at
$1.7M
Sold 53,034 shares
@ $23.2195, valued at
$1.2M
Exercised 87,645 options to buy
@ $7.2, valued at
$631k
Exercised 66,775 options to buy
@ $7.2, valued at
$480.8k
Exercised 53,034 options to buy
@ $10.9, valued at
$578.1k
Exercised 71,966 options to buy
@ $7.2, valued at
$518.2k
|
|
| 09/16/2022 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 66,840 shares
@ $24.1978, valued at
$1.6M
Sold 5,419 shares
@ $23.4327, valued at
$127k
Sold 6,556 shares
@ $23.4327, valued at
$153.6k
Exercised 66,840 options to buy
@ $6.32, valued at
$422.4k
Exercised 6,556 options to buy
@ $6.35, valued at
$41.6k
Exercised 5,419 options to buy
@ $6.32, valued at
$34.2k
|
|
| 08/26/2022 |
4
| Ordentlich Peter (Chief Scientific Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Acquired 265 shares
@ $14.12, valued at
$3.7k
Sold 22,846 shares
@ $25.0357, valued at
$572k
Sold 2,154 shares
@ $25.0357, valued at
$53.9k
Exercised 2,154 options to buy
@ $6.35, valued at
$13.7k
Exercised 22,846 options to buy
@ $6.32, valued at
$144.4k
|
|
| 08/09/2022 |
4
| Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 10,000 shares
@ $23.0159, valued at
$230.2k
Sold 14,000 shares
@ $23.0159, valued at
$322.2k
Exercised 10,000 options to buy
@ $9.63, valued at
$96.3k
Exercised 14,000 options to buy
@ $8.93, valued at
$125k
|
|
| 07/27/2022 |
4
| Metzger Michael A (CEO) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 19,764 shares
@ $21.0554, valued at
$416.1k
Sold 11,838 shares
@ $21.0554, valued at
$249.3k
Exercised 19,764 options to buy
@ $6.38, valued at
$126.1k
Exercised 11,838 options to buy
@ $6.38, valued at
$75.5k
|
|
|
|
|